You’re invited! Register now to access FUJIFILM Diosynth Biotechnologies’ Cell and Gene capacity update, led by our very own Sara Miller, Cell Therapy Business Steering Group Lead, on July 25th, 2024. This webinar will offer a glimpse into the flexible and smart designs included in the capacity expansion project from significant investment in cell therapy services at our Thousand Oaks facility. This talk will showcase examples of flexibility and state-of-the art designs to ensure that every Cell Therapy program, no matter where it is on the journey from discovery to marketing authorization, can be produced at FUJIFILM Diosynth Biotechnologies' California facilities. Register now: https://lnkd.in/eNKiSKzH
FUJIFILM Diosynth Biotechnologies
Biotechnology Research
Partners for Life, Advancing Tomorrow's Medicines
About us
For over 30 years, FUJIFILM Diosynth Biotechnology’s mission has been advancing tomorrow’s medicine. As a CDMO, we work in partnership with the most innovative biopharma and biotech companies across the world who are reimagining healthcare’s potential. We help to accelerate their progress, expand their capabilities, streamline their processes, and strengthen their innovation. So when our customers’ potential cures, vaccines, biologics, and accomplishments make strides – or even become new realities for patients – we know our work, our manufacturing expertise, and our partnership helped make it happen. FDB isn’t simply a workplace. It’s a place of passion – a place of what we call Genki. A place where diverse perspectives and people come to life. Where opportunity for growth has no end. Where passion is followed, discovered, and nurtured. Where the energy is undeniable, enthusiasm is pervasive, and drive is infectious. All of our global locations burst with curiosity, inspiration, and extraordinary purpose. So as we continue to grow our teams, our global locations, and our capabilities, Genki will always be our cultural tie. That’s why we’re always looking for passionate, mission-driven people who want to commit their life’s work to enabling better outcomes for patients and their families. For a full listing of jobs that will propel, inspire, and fulfill you, please visit: fujifilmdiosynth.com/careers/ We created this space on LinkedIn to give people a window into work and culture at FDB. We’re highlighting employees’ passion, current openings, and why it’s never been a more exciting time to join FDB.
- Website
-
http://www.fujifilmdiosynth.com
External link for FUJIFILM Diosynth Biotechnologies
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Billingham
- Type
- Public Company
- Founded
- 2011
- Specialties
- Biologics Process Development and Biologics cGMP Manufacturing
Locations
Employees at FUJIFILM Diosynth Biotechnologies
Updates
-
We are thrilled to announce we are a presenting sponsor at the Outsourced Pharma Capacity Update on July 22nd! Join Nadiyra Walker Speight, Head of Drug Product and Finished Goods Manufacturing in Holly Springs, NC, for an exciting update on our current and future capabilities. Learn about our end-to-end CDMO services, the latest on our Drug Product and Finished Goods capacity, and our newest partnerships. Check out the full agenda and register for free today! https://lnkd.in/eVMh72Kc
-
It’s never too early to start thinking about Process Characterization. Dr. Lee Johnson shares his thoughts on critical early considerations to ensure success. #science #cdmo #biotech #biotechnologies
-
Our Process Development teams leverage extensive knowledge in microbial-based biologic processes, enabling the design of efficient development strategies. Our Gene-to-Toxicology program offers a streamlined set of services to efficiently progress microbial biologics to toxicology trials. Learn more in our latest article! https://lnkd.in/ecUGmgiz
-
Our site in Hillerød, Denmark, found a partner in The Technical University of Denmark to assist with training that will support hiring more than 750 people in a concise time frame. DTU's willingness to customize the course “Introduction to Biomanufacturing Operations: Drug Substances” for our unique needs ensures that we equip potential employees with the necessary knowledge and insights needed to navigate the complexities of biomanufacturing operations. Our partnership with DTU Biotech Lifelong Learning enables us to offer this tailored course to our employees multiple times a year. We are committed to providing our employees with excellent learning opportunities. By collaborating with esteemed educational institutions like DTU, we solidify our dedication to fostering a culture of continuous learning, innovation, and professional development. In investing in customized education, we believe we empower our employees to excel in their respective positions. To learn more about our tailored education initiatives and explore the opportunities available at FUJIFILM Diosynth Biotechnologies, visit our website: https://lnkd.in/gyHaw4Zd #employeeeducation #professionaldevelopment #learning #biomanufacturing #alwaysgrowing
-
FUJIFILM Diosynth Biotechnologies reposted this
This week, Toshihisa Iida, Director, Corporate Vice President, General Manager of the Life Science Strategy Headquarters and Bio CDMO Division / Chairman of FUJIFILM Diosynth Biotechnologies joined the Honorable Greg Abbott, Governor of Texas as well as other key Texas economic development leaders for a luncheon in #Tokyo as part of Texas' Asia trade and economic development delegation. We'd like to extend our sincere gratitude to Governor Abbott, his team and the wonderful people of Texas for their continued support and partnership 🤝 of our #biomanufacturing operations in College Station, Texas. We look forward to continuing to have a positive impact in the communities we operate in and making the #biocorridor a thriving #lifesciences community.
-
Breaking new ground in VGT development 🧬 High dose delivery has long been an industry bottleneck, but Fujifilm BSEL is leading the charge with a revolutionary continuous electroporation device. Historically hindered by low throughput and poor cell viability, this new technology promises to eliminate the need for chemically mediated transfection. Set to debut in our Texas demo labs in early 2025, this device is poised to boost vector productivity, streamline manufacturing, and make VGTs more economically viable. Read more here: https://lnkd.in/eFyTpTzW
-
FUJIFILM Diosynth Biotechnologies reposted this
It was a pleasure to join The Honorable Greg Abbott, Governor of Texas, and the state’s representatives for this event. On behalf of all Fujifilm’s people in Texas, thank you for the leadership you and your administration provide. We know why Texas is one of the top states in the US for business.
The fourth day of our economic development mission took us to Nagoya, Japan, where we had an enriching experience focused on bolstering our relationship with Toyota and Japanese businesses. I met with Toyota executives at the Toyota Commemorative Museum of Industry and Technology. Toyota has been a vital part of Texas’s economy for over 20 years. Their significant investments in manufacturing facilities in Plano and San Antonio have brought thousands of good-paying jobs to hardworking Texans. Later, I met with executives from Aisin to discuss our long-standing partnership and future collaborative efforts in automotive manufacturing. I also thanked them for their recent investment in Cibolo. I look forward to continuing our economic development mission as we build a more innovative future for both Texas and Japan. Learn more about our day here: https://bit.ly/3S3U3Tz
-
We are delighted to announce we will be co-exhibiting at BIO Asia Taiwan, July 24-28, 2024, in Taiwan. Schedule a meeting with our team via One-to-One partnering or stop by the Fujifilm booth M208 to learn more about FUJIFILM Diosynth Biotechnologies’ capabilities and how we can help you advance and deliver tomorrow’s medicines. #BIOAsiaTaiwan #TaiwanEvents #PharmaIndustry #Biotech
-
Autoinjectors, traditionally used for diabetes and autoimmune conditions, are now expanding into oncology and metabolic disease markets, empowering patients to manage their treatments at home, reducing travel time and costs. FUJIFILM Diosynth Biotechnologies and SHL Medical have partnered to enhance drug delivery solutions, combining SHL's expertise in self-injection devices with FDB's robust manufacturing capabilities. This collaboration ensures patients receive high-quality, user-friendly autoinjectors quickly and safely, revolutionizing patient care. https://lnkd.in/ewcifZ_A #Autoinjectors #MetabolicDisease #DrugDelivery #PatientCare #MedicalDevices #HealthcareInnovation #Biotechnology #MedicalManufacturing